[1] A fellow of the Academy of Medical Sciences, Goodwin has served as principal investigator in many clinical trials for the treatment of bipolar disorder.
[1] Goodwin was the principal investigator of many clinical trials for treatments of bipolar affective disorder, including the BALANCE, CEQUEL, and OXTEXT studies.
After completing his DPhil in Neurophysiology at Oxford, Goodwin qualified in psychiatry and went on to become a Clinical Scientist and Consultant Psychiatrist in the MRC Brain Metabolism Unit at the University of Edinburgh for 10 years.
[8] From 1997 to 2007, he was the non-executive Director and Vice-Chair of the Oxfordshire and Buckinghamshire NHS Mental Health Trust Board.
Goodwin has served on numerous advisory boards including the Evaluation committee for neuroscience, neurology, and psychiatry of the Agence Nationale de Recherche, France, the Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, and Medical Research Council's Clinical fellowships panel and Advisory Board.